Stocks
G1 Therapeutics (GTHX) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -210.9% | -452.6% | -263.0% | -263.0% | -47.3% | -60.9% | ||
| Changes by years, y/y, % | -242pp | +190pp | 0pp | +216pp | -39.2% | ||||
G1 Therapeutics. EBITDA margin, %
G1 Therapeutics. EBITDA margin, changes, pp
G1 Therapeutics (GTHX) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA margin, % | ? | 30.3% | -122.4% | -59.2% | -61.7% | -15.8% | -60.9% | |
| Changes by years, y/y, % | +379pp | -33pp | +234pp | +128pp | -46pp | |||
| Changes by quarters, q/q, % | +220pp | -153pp | +63pp | -2pp | +46pp | |||
